Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.

Juan G AbraldesChristophe BureauHoria StefanescuSalvador AugustinMichael NeyHélène BlascoBogdan ProcopetJaime BoschJoan GenescàAnnalisa Berzigottinull null

Published in: Hepatology (Baltimore, Md.) (2016)

A significant proportion of patients with a very high risk of CSPH, and a population with a very low risk of VNT can be identified with simple, noninvasive tests, suggesting that these can be used to individualize medical care. (Hepatology 2016;64:2173-2184).

Keyphrases

blood pressure
arterial hypertension